Which has preferable valuation & earnings, BACK or IMAC?

IMAC has higher earnings, but lower revenue than IMAC. IMAC is trading at a lower price-to-earnings ratio than IMAC, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio IMAC $72.05K 0.02 -$9.42M -$3.12 N/A IMAC $15.22M 0.00 -$10.54M -$0.27 N/A

Is BACK or IMAC more profitable?

IMAC has a net margin of 0.00% compared to IMAC's net margin of -75.40%. IMAC's return on equity of 0.00% beat IMAC's return on equity. Company Net Margins Return on Equity Return on Assets IMAC N/A N/A -325.44% IMAC -75.40% -52.17% -34.51%

Which has preferable valuation & earnings, IMAC or AONCW?

American Oncology Network has higher revenue and earnings than IMAC. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio IMAC $15.22M 0.00 -$10.54M -$0.27 N/A American Oncology Network $1.34B N/A N/A N/A N/A

Do analysts recommend BTSGU or IMAC?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BrightSpring Health Services 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 IMAC 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has preferable earnings and valuation, BTSGU or IMAC?

BrightSpring Health Services has higher revenue and earnings than IMAC. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio BrightSpring Health Services $14.37B N/A N/A N/A N/A IMAC $15.22M 0.00 -$10.54M -$0.27 N/A

Which has preferable valuation and earnings, IMAC or WGSWW?

GeneDx has higher revenue and earnings than IMAC. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio IMAC $15.22M 0.00 -$10.54M -$0.27 N/A GeneDx $442.68M N/A N/A N/A N/A

Is IMAC or WGSWW more profitable?

GeneDx has a net margin of 0.00% compared to IMAC's net margin of -75.40%. GeneDx's return on equity of 0.00% beat IMAC's return on equity. Company Net Margins Return on Equity Return on Assets IMAC -75.40% -52.17% -34.51% GeneDx N/A N/A N/A

Which has stronger valuation and earnings, LFMDP or IMAC?

LifeMD has higher revenue and earnings than IMAC. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio LifeMD $191.59M N/A N/A N/A N/A IMAC $15.22M 0.00 -$10.54M -$0.27 N/A

Is LFMDP or IMAC more profitable?

LifeMD has a net margin of 0.00% compared to IMAC's net margin of -75.40%. LifeMD's return on equity of 0.00% beat IMAC's return on equity. Company Net Margins Return on Equity Return on Assets LifeMD N/A N/A N/A IMAC -75.40% -52.17% -34.51%

IMAC (IMAC) Competitors

$0.0003 0.00 (-25.00%)

As of 08/10/2026

Compare

IMAC vs. BACK, AONCW, BTSGU, WGSWW, and LFMDP

Should you buy IMAC stock or one of its competitors? IMAC's main competitors and comparable companies include IMAC (BACK), American Oncology Network (AONCW), BrightSpring Health Services (BTSGU), GeneDx (WGSWW), and LifeMD (LFMDP). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare providers & services" industry.

How does IMAC compare to IMAC?

IMAC (NASDAQ:BACK) and IMAC (NASDAQ:IMAC) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, earnings, profitability, media sentiment, valuation and risk.

5.8% of IMAC shares are owned by institutional investors. Comparatively, 24.3% of IMAC shares are owned by institutional investors. 12.3% of IMAC shares are owned by company insiders. Comparatively, 10.0% of IMAC shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

IMAC has higher earnings, but lower revenue than IMAC. IMAC is trading at a lower price-to-earnings ratio than IMAC, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IMAC	$72.05K	0.02	-$9.42M	-$3.12	N/A
IMAC	$15.22M	0.00	-$10.54M	-$0.27	N/A

In the previous week, IMAC had 1 more articles in the media than IMAC. MarketBeat recorded 1 mentions for IMAC and 0 mentions for IMAC. IMAC's average media sentiment score of 1.34 beat IMAC's score of 0.87 indicating that IMAC is being referred to more favorably in the media.

Company	Overall Sentiment
IMAC	Positive
IMAC	Positive

IMAC has a net margin of 0.00% compared to IMAC's net margin of -75.40%. IMAC's return on equity of 0.00% beat IMAC's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IMAC	N/A	N/A	-325.44%
IMAC	-75.40%	-52.17%	-34.51%

IMAC has a beta of 1.78, suggesting that its stock price is 78% more volatile than the broader market. Comparatively, IMAC has a beta of -0.88, suggesting that its stock price is 188% less volatile than the broader market.

Summary

IMAC beats IMAC on 9 of the 13 factors compared between the two stocks.

How does IMAC compare to American Oncology Network?

IMAC (NASDAQ:IMAC) and American Oncology Network (NASDAQ:AONCW) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, valuation, analyst recommendations, institutional ownership, media sentiment, earnings, profitability and dividends.

American Oncology Network has a net margin of 0.00% compared to IMAC's net margin of -75.40%. American Oncology Network's return on equity of 0.00% beat IMAC's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IMAC	-75.40%	-52.17%	-34.51%
American Oncology Network	N/A	N/A	N/A

24.3% of IMAC shares are held by institutional investors. 10.0% of IMAC shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

American Oncology Network has higher revenue and earnings than IMAC.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IMAC	$15.22M	0.00	-$10.54M	-$0.27	N/A
American Oncology Network	$1.34B	N/A	N/A	N/A	N/A

In the previous week, IMAC's average media sentiment score of 0.87 beat American Oncology Network's score of 0.00 indicating that IMAC is being referred to more favorably in the media.

Company	Overall Sentiment
IMAC	Positive
American Oncology Network	Neutral

Summary

American Oncology Network beats IMAC on 4 of the 7 factors compared between the two stocks.

How does IMAC compare to BrightSpring Health Services?

BrightSpring Health Services (NASDAQ:BTSGU) and IMAC (NASDAQ:IMAC) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, dividends, media sentiment, institutional ownership, valuation, risk, analyst recommendations and earnings.

BrightSpring Health Services has higher revenue and earnings than IMAC.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BrightSpring Health Services	$14.37B	N/A	N/A	N/A	N/A
IMAC	$15.22M	0.00	-$10.54M	-$0.27	N/A

24.3% of IMAC shares are held by institutional investors. 10.0% of IMAC shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

In the previous week, BrightSpring Health Services had 1 more articles in the media than IMAC. MarketBeat recorded 1 mentions for BrightSpring Health Services and 0 mentions for IMAC. IMAC's average media sentiment score of 0.87 beat BrightSpring Health Services' score of 0.00 indicating that IMAC is being referred to more favorably in the news media.

Company	Overall Sentiment
BrightSpring Health Services	Neutral
IMAC	Positive

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BrightSpring Health Services	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
IMAC	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

BrightSpring Health Services has a net margin of 0.00% compared to IMAC's net margin of -75.40%. BrightSpring Health Services' return on equity of 0.00% beat IMAC's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
BrightSpring Health Services	N/A	N/A	N/A
IMAC	-75.40%	-52.17%	-34.51%

Summary

BrightSpring Health Services beats IMAC on 6 of the 9 factors compared between the two stocks.

How does IMAC compare to GeneDx?

IMAC (NASDAQ:IMAC) and GeneDx (NASDAQ:WGSWW) are both healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, earnings, media sentiment, risk, profitability, analyst recommendations and dividends.

GeneDx has a net margin of 0.00% compared to IMAC's net margin of -75.40%. GeneDx's return on equity of 0.00% beat IMAC's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IMAC	-75.40%	-52.17%	-34.51%
GeneDx	N/A	N/A	N/A

GeneDx has higher revenue and earnings than IMAC.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IMAC	$15.22M	0.00	-$10.54M	-$0.27	N/A
GeneDx	$442.68M	N/A	N/A	N/A	N/A

24.3% of IMAC shares are held by institutional investors. 10.0% of IMAC shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

In the previous week, IMAC's average media sentiment score of 0.87 beat GeneDx's score of 0.00 indicating that IMAC is being referred to more favorably in the media.

Company	Overall Sentiment
IMAC	Positive
GeneDx	Neutral

Summary

GeneDx beats IMAC on 4 of the 7 factors compared between the two stocks.

How does IMAC compare to LifeMD?

LifeMD (NASDAQ:LFMDP) and IMAC (NASDAQ:IMAC) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, dividends, risk, valuation, profitability, analyst recommendations and media sentiment.

24.3% of IMAC shares are owned by institutional investors. 10.0% of IMAC shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

LifeMD has higher revenue and earnings than IMAC.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LifeMD	$191.59M	N/A	N/A	N/A	N/A
IMAC	$15.22M	0.00	-$10.54M	-$0.27	N/A

LifeMD has a net margin of 0.00% compared to IMAC's net margin of -75.40%. LifeMD's return on equity of 0.00% beat IMAC's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LifeMD	N/A	N/A	N/A
IMAC	-75.40%	-52.17%	-34.51%

In the previous week, LifeMD had 1 more articles in the media than IMAC. MarketBeat recorded 1 mentions for LifeMD and 0 mentions for IMAC. IMAC's average media sentiment score of 0.87 beat LifeMD's score of 0.00 indicating that IMAC is being referred to more favorably in the news media.

Company	Overall Sentiment
LifeMD	Neutral
IMAC	Positive

Summary

LifeMD beats IMAC on 5 of the 8 factors compared between the two stocks.

Get IMAC News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IMAC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

IMAC vs. The Competition

Export

Metric	IMAC	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$8K	$9.88B	$7.00B	$12.83B
Dividend Yield	N/A	2.55%	2.58%	10.06%
P/E Ratio	0.00	24.93	268.64	24.75
Price / Sales	0.00	4.79	583.07	96.14
Price / Cash	N/A	25.58	28.89	37.42
Price / Book	0.00	5.24	11.32	6.44
Net Income	-$10.54M	$307.72M	$3.44B	$347.05M
7 Day Performance	N/A	-0.45%	2.27%	0.97%
1 Month Performance	N/A	-0.58%	-0.21%	-0.65%
1 Year Performance	N/A	20.71%	76.23%	22.24%

IMAC Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
IMAC IMAC	N/A	$0.00 -25.0%	N/A	-99.5%	$8K	$15.22M	N/A	106	Gap Down
BACK IMAC	N/A	$0.00 flat	N/A	-99.6%	$2K	$72.05K	N/A	180	Positive News Upcoming Earnings
AONCW American Oncology Network	N/A	$0.00 flat	N/A	N/A	$0.00	$1.34B	N/A	1,525
BTSGU BrightSpring Health Services	N/A	$208.12 +1.8%	N/A	+178.5%	$0.00	$14.37B	N/A	35,000
WGSWW GeneDx	N/A	$0.00 flat	N/A	N/A	$0.00	$442.68M	N/A	1,000

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:IMAC) was last updated on 8/11/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

IMAC (IMAC) Competitors